See also this year's filing and all EDGAR filings for this company.
PDF Report 0001107421_2019_Alaunos_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001107421, Alaunos Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 84,285,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,097,000 |
| 3 | remainder_Assets | 9,669,000 |
| 4 | LiabilitiesCurrent | 9,483,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 4,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 19,918,000 |
| 9 | ResearchAndDevelopmentExpense | 34,134,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 146,000 |
| 12 | remainder_NetIncome | 789,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 95,051,000 |
| 1 | Liabilities | 9,487,000 |
| 2 | Expenses | 54,052,000 |
| 3 | Revenues | 146,000 |
| 4 | StockholdersEquity | 85,564,000 |
| 5 | NetIncome | -53,117,000 |
| 6 | ComprehensiveNetIncome | -53,117,000 |
| 7 | BaseVar | 79,762,500 |
| 8 | EconomicCapitalRatio | 1.80 |
Edgar->Model Mapping
Feature Distribution
Change over Time
